Is akba a good buy

**Akebia Therapeutics (AKBA) does not appear to be a good buy at this time**, based on several factors:

1. **Recent Performance**: The closing price of AKBA on July 25, 2024, was $1.48, which is below the 52-week range of $0.78 to $2.48. This suggests that the stock may be undervalued, but it also indicates a lack of positive momentum.

|Ticker|Name|Closing Price|Date|code|market_code|
|---|---|---|---|---|---|
|AKBA.O|Akebia Therapeutics|1.48|20240725|AKBA|186|

2. **Trend Analysis**: The stock's 5-day, 10-day, and 20-day moving averages are $1.43, $1.39, and $1.2, respectively. The fact that the shorter-term moving averages are below the longer-term averages indicates a bearish trend.

|Ticker|Name|5-Day Moving Average|20-Day Moving Average|10-Day Moving Average|Date|code|market_code|
|---|---|---|---|---|---|---|---|
|AKBA.O|Akebia Therapeutics|1.4280|1.2011|1.3900|20240725|AKBA|186|

3. **Fund Flow**: There was a net fund outflow of $42100.8 on July 25, 2024, which could be a sign of investor pessimism or a lack of confidence in the stock's future performance.

4. **Financial Health**: AKBA has a negative revenue growth rate of -18.49% and a net loss of $17.99 million. These figures indicate that the company is not growing and is currently unprofitable.

5. **Analyst Ratings and Targets**: There is no available data on the analyst consensus rating or average price target for AKBA. However, the lack of positive momentum and the company's financial performance suggest that analysts may not be optimistic about the stock's future performance.
6. **Pipeline**: The company's pipeline information is not provided, which makes it difficult to assess the potential for future product launches and revenue growth.

In conclusion, given the negative recent performance, bearish technical indicators, significant net fund outflow, financial losses, and lack of positive analyst sentiment, Akebia Therapeutics does not appear to be a good buy at this time. Investors should exercise caution and consider these factors before making an investment decision.